ArticleJournal of assisted reproduction and genetics2025
Successful pre-implantation genetic testing for autosomal recessive cutis laxa: clinical utility of a multidisciplinary team approach.
Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The impact of preimplantation genetic testing on the quality of life of people undergoing assisted reproduction treatment.Scientific reports · 2026Observational
- Case Report: Preventing X-linked retinoschisis transmission via MARSALA-based PGT-M.Frontiers in ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposePre-implantation genetic testing for monogenic disorders (PGT-M) enables couples at risk of transmitting serious genetic disorders to their offspring to give birth to healthy children. Here, we present an illustrative case of the use of PGT-M in a couple who were both carriers of autosomal recessive cutis laxa (ARCL) and describe the application of PGT-M in our reproductive center using a multidisciplinary team approach.
methodsThe couple experienced four adverse pregnancy outcomes, and both partners were subsequently identified as carriers of ARCL caused by PYCR1 gene variants during a genetic evaluation. They chose PGT-M after counseling and being fully informed of the potential risks and benefits. Trophectoderm cells were biopsied on day 5 or 6 and whole-genome amplification was performed using multiple annealing and looping-based amplification cycles (MALBAC). Mutated allele revealed by sequencing with aneuploidy and linkage analysis (MARSALA) was used to detect the copy number variations and the carrier status of the PYCR1 gene. Prenatal diagnosis was performed to validate the PGT-M results. Psychological support was provided throughout.
resultsPGT-M was successfully performed, and transfer of a euploid blastocyst carrying a paternal variant in the third cycle resulted in a pregnancy. Prenatal diagnosis confirmed the PGT-M results. The woman gave birth to a healthy boy with normal skin and growth and developmental milestones.
conclusionThis study illustrates the clinical applicability of PGT-M in ARCL carrier couples, highlighting the importance of multidisciplinary consultation, and the implementation of comprehensive genetic counseling protocols and tailored psychosocial interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.